TP53 and B-cell chronic lymphocytic leukemia: First, it is among the few cancers where TP53 alterations have been incorporated into routine clinical diagnostics to improve patient stratification, and, second, the landscape of TP53 mutations in CLL finds no equivalent in other cancer types and inspires research to improve our understanding of this still incurable disease [10, 33–35].